International Patent: DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING C5-MEDIATED GLOMERULAR NEPHRITIS (GN), INCLUDING IGA NEPHROPATHY (IGAN) AND/OR IGA VASCULITIS NEPHRITIS (IGAVN) IN PEDIATRIC PATIENTS

GENEVA, July 27 -- ALEXION PHARMACEUTICALS, INC. filed a patent application (US2026/011349) for “DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING C5-MEDIATED GLOMERULAR NEPHRITIS (GN), INCLUDING IGA NEPHROPATHY (IGAN) AND/OR IGA VASCULITIS NEPHRITIS (IGAVN) IN PEDIATRIC PATIENTS”. With publication no. WO/2026/156119, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: C07K 16/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....